long covid

Long COVID: a new word for naming fibromyalgia? Xavier Mariette Long COVID is the name given to a syndrome comprising a wide variety of symptoms persisting more than 3 months after acute benign COVID-19, with a prevalence ranging from 10 to 80%. Symptoms are very close to fibromyalgia. Several...

Probing long COVID through a proteomic lens: a comprehensive two-year longitudinal cohort study of hospitalised survivors Background As a debilitating condition that can impact a whole spectrum of people and involve multi-organ systems, long COVID has aroused the most attention than ever...

Abstract Previous efforts to estimate the burden of fatigue-related symptoms due to long COVID have a very high threshold for inclusion of cases, relative to the proposed definition from the World Health Organization. In practice this means that milder cases, that may be occurring very...

Long COVID in the United States David G. Blanchflower; Alex Bryson Although yet to be clearly identified as a clinical condition, there is immense concern at the health and wellbeing consequences of long COVID. Using data collected from nearly half a million Americans in the period June...

Return-to-work with long COVID: An Episodic Disability and Total Worker Health® analysis Stelson; Dash; McCorkell; Wilson; Assaf; Re'em; Wei A growing number of working individuals have developed long COVID (LC) after COVID-19 infection. Economic analyses indicate that workers’ LC symptoms...

Abstract The association between the stiffening of barosensitive regions of central arteries and the derangements in baroreflex functions remains unexplored in COVID-19 survivors. Fifty-seven survivors of mild COVID-19 (defined as presence of upper respiratory tract symptoms and/or fever...

Now published - details here ********** Preprint Characterization of Unique Pathological Features of COVID-Associated Coagulopathy: Studies with AC70 hACE2 Transgenic Mice Highly Permissive to SARS-CoV-2 Infection Aleksandra K Drelich; Kempaiah Rayavara; Jason Hsu; Panatda Saenkham-Huntsinger...

Long-term Prognosis at 1.5 years after Infection with Wild-type strain of SARS-CoV-2 and Alpha, Delta, as well as Omicron Variants Jane Agergaard; Jesper Damsgaard Gunst; Berit Schiøttz-Christensen; Lars Østergaard; Christian Wejse Objectives Knowledge is limited on how changing SARS-CoV-2...

Sequential multi-omics analysis identifies clinical phenotypes and predictive biomarkers for long COVID Kaiming Wang; Mobin Khoramjoo; Karthik Srinivasan; Paul M.K. Gordon; Rupasri Mandal; Dana Jackson; Wendy Sligl; Maria B. Grant; Josef M. Penninger; Christoph H. Borchers; David S. Wishart...

Published abstract and link here Preprint Complement dysregulation is a predictive and therapeutically amenable feature of long COVID Background: Long COVID encompasses a heterogeneous set of ongoing symptoms that affect many individuals after recovery from infection with severe acute...

A new US non-profit 501(c)(3) org has been announced: Long COVID Foundation (LCF): Website: https://www.longcfoundation.org Partners: @LongCovidAP @LCawarenessInt @React19org Long COVID Foundation @LongCFoundation We are very pleased to announce the official beginning of the “Long...

COVID-19 disease, caused by the severe acute respiratory syndrome virus 2 (SARS-CoV-2), induces a broad spectrum of clinical symptoms ranging from asymptomatic cases to fatal outcomes. About 10–35% of all COVID-19 patients, even those with mild COVID-19 symptoms, continue to show symptoms...

This thread includes posts on general news from the CDC and ME/CFS news including stakeholder calls. Several threads have been merged.

Validation of ANG-1 and P-SEL as biomarkers of post-COVID-19 conditions using data from the Biobanque québécoise de la COVID-19 (BQC-19) The quest for understanding and managing the long-term effects of COVID-19, often referred to as Long COVID or post-COVID-19 condition (PCC), remains an...

SARS-CoV-2 induces acute neurological signs while Calcitonin Gene-Related Peptide CGRP signaling blockade reduces interleukin 6 IL-6 release and weight loss in mouse models Shafaqat M Rahman; David W Buchholz; Brian Imbiakha; Mason C Jaeger; Justin Leach; Raven M Osborn; Ann O Birmingham...

Persistent post-COVID headache is associated with suppression of scale-free functional brain dynamics in non-hospitalized individuals Nathan W. Churchill; Eugenie Roudaia; J. Jean Chen; Asaf Gilboa; Allison Sekuler; Xiang Ji; Fuqiang Gao; Zhongmin Lin; Mario Masellis; Maged Goubran; Jennifer S...

Long article Clare Sansom is a science writer based in Cambridge, UK https://www.chemistryworld.com/features/battling-long-covid-with-drugs/4018238.article

NEW & NOTEWORTHY Using novel methodology quantifying intrapulmonary shunt and alveolar dead space in COVID-19 patients up to 403 days after acute illness, 37% had increased intrapulmonary shunt and 86% had elevated alveolar dead space likely due to independent pathology. Elevated shunt was...

Published version linked in this later post here Preprint Abstract The COVID-19 pandemic caused by SARS-CoV-2 has triggered a consequential public health crisis of post-acute sequelae of COVID-19 (PASC), sometimes referred to as long COVID. The mechanisms of the heterogeneous persistent...

Healthcare Utilisation of 282,080 Individuals with Long COVID Over Two Years: A Multiple Matched Control Cohort Analysis Mu, Yi; Dashtban, Ashkan; Mizani, Mehrdad A.; Tomlinson, Christopher; Mohamed, Mohamed; Ashworth, Mark; Mamas, Mamas; Priedon, Rouven; Petersen, Steffen E.; Kontopantelis...